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Physical disruption of cell–cell contact induces VEGF expression
in RPE cells
Farhad Farjood, Elizabeth Vargis
Department of Biological Engineering, Utah State University, Logan, UT
Purpose: To investigate the role of RPE cell–cell contact in vascular endothelial growth factor (VEGF) protein expression in cultures of primary human RPE (hRPE) cells and a human RPE cell line (ARPE-19).
Methods: Two in vitro methods, scratching and micropatterning, were used to control the physical dissociation of RPE
cell–cell junctions. Scratching was performed by scoring monolayers of RPE cells with a cell scraper. Micropatterning
was achieved by using a stencil patterning method. Extracellular VEGF expression was assessed by using an enzymelinked immunosorbent assay (ELISA) kit. Immunocytochemistry (ICC) was performed to visualize the expression and
localization of VEGF and intercellular proteins zonula occludens-1 (ZO-1), N-cadherin, β-catenin, and claudin-1 in
RPE cultures.
Results: Higher expression of VEGF protein by cells on the edges of the scratched RPE layers was confirmed with
ICC in short-term (1 day after confluency) and long-term (4 weeks after confluency) cultures. According to the ICC
results, ZO-1, N-cadherin, β-catenin, and claudin-1 successfully localized to cell–cell junctions in long-term cultures
of ARPE-19 and hRPE cells. However, unlike N-cadherin, β-catenin, and claudin-1, only ZO-1 localized junctionally in
short-term cultures of both cell types. Moreover, removing cell–cell junctions by scratching resulted in the delocalization
of ZO-1 from tight junctions to the cytoplasm. The loss of tight junction formation and the accumulation of ZO-1 in the
cytoplasm correlated with increased VEGF expression. Micropatterning RPE cells on different sized circular patterns
produced varying concentrations of cells with lost cell–cell junctions. When fewer cells formed intercellular junctions,
increased extracellular VEGF secretion was observed from the ARPE-19 and hRPE cells.
Conclusions: VEGF expression increases after physical disruption of RPE cell–cell connections. This increase in VEGF
expression correlates with the loss of intercellular junctions and the localization of ZO-1 in the cytoplasm of RPE cells.

to antagonize VEGF, slow vision loss, and improve visual
acuity [6-10].

The exudative (wet) form of age-related macular degeneration (AMD) is characterized by the abnormal growth of
new leaky blood vessels in the choroid (choroidal neovascularization, CNV) and near the macula. CNV can cause RPE
deformation and degeneration, leading to the irreversible loss
of vision [1,2]. Although the exact causes of CNV are not
completely understood, RPE-derived vascular endothelial
growth factor (VEGF), a potent angiogenesis factor, is generally thought to be the major stimulator of CNV [3-10].

Even though anti-VEGF products slow the progression
of CNV, there is no cure or prevention for CNV associated with wet AMD. The exact mechanisms resulting in
the overexpression of angiogenic factors, including VEGF,
in RPE cells remain unknown. A wide range of molecular
and environmental factors has been implicated in elevated
VEGF expression by RPE cells, including hypoxia [13-16]
and inflammation due to increased levels of inflammatory
cytokines or drusen components, such as C3a, C5a, and
amyloid β [17-19].

Appropriate levels of VEGF are crucial for the normal
development of the choroid [11,12]. VEGF also functions as
an important factor in maintaining RPE and endothelial cells
[11]. However, abnormal levels of VEGF are also associated
with retinal disease [3]. Moreover, overexpressing VEGF in
rat RPE results in the development of CNV [4,5]. Accordingly,
VEGF has been the foremost target in many experimental
studies and clinical trials to inhibit CNV. The most successful
treatment for CNV in wet AMD uses recombinant anti-VEGF

Reduced RPE cell–cell adhesion, caused by RPE tears
or RPE cell death in the latest stages of dry AMD, may also
elevate VEGF gene expression. RPE tears occur during AMD
from RPE detachment or CNV [20-24] and most commonly
from intravitreal injection of anti-VEGF drugs during treatment [24-28]. RPE cell death, mediated by apoptosis and/
or necrosis, in geographic atrophy (GA) is another in vivo
phenomenon through which the physical contact between
RPE cells is lost [29-31]. Two separate studies reported
increased mRNA levels of VEGF after calcium-mediated
dissociation of RPE cell–cell junctions [32,33].
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However, because the exact effect of extracellular
calcium ions on VEGF expression is unclear, alternative in
vitro methods may elucidate the role of physical cell–cell
adhesion in VEGF expression. Moreover, none of these
studies, to our knowledge, has demonstrated how junctional cell–cell detachment affects the expression of the
VEGF protein. In this work, we used two in vitro methods,
scratching and micropatterning, without introducing exogenous components to study the role of RPE cell–cell adhesion
in VEGF protein expression.
Scratching assays, also known as wound healing assays,
are generally used to mimic tissue damage and study the
proliferation and migration capability of cells [34,35].
Scratching has also been used to study the molecular events
associated with the loss of cell–cell contact in RPE cells
[36]. Specifically, the expression of platelet-derived growth
factor (PDGF) increased in cells on the leading edge of a
scratched RPE layer [37]. Another analysis demonstrated
that scratching a monolayer of ARPE-19 cells altered the
expression of the genes encoding hepatoma-derived growth
factor (HDGF), mitogen-activated protein kinase, CD44, and
other proteins [38]. Here, we used scratching assays to mimic
damage to the RPE monolayer resulting from RPE degeneration in AMD and to study the changes in VEGF expression
in RPE cells surrounding the scratched edge.
Although the scratching assay provides a view of differential VEGF expression in RPE cells around the edges, the
extent of cell–cell contact loss cannot be well controlled.
Accordingly, we also developed a micropatterning method
to control cell–cell contact and study VEGF expression.
Micropatterning techniques provide a platform to control
spatial distribution of cells on various substrates and reconstruct the architecture of in vivo tissue. Micropatterning is a
powerful tool for engineering the differentiation and function of cells [39,40], making in vitro tissue models [41], and
studying cell–cell interactions [42]. A variety of micropatterning methods with different complexities and applications is currently available [43]. Most of these methods use
cell adhesion proteins to promote cell adhesion to specific
areas of substrates [44]. However, it has been shown that cell
adhesion proteins can affect VEGF expression [14]. Stencil
patterning, a new method of patterning, is a straightforward
and reproducible alternative technique, which eliminates the
need for cell adhesion proteins [45,46].
In the present study, an in vitro scratching method
was used to mechanically dissociate cell–cell junctions in
ARPE-19 (a human RPE cell line derived from a 19-year-old
man) and human primary RPE (hRPE) cells. Both cell types
are capable of expressing RPE markers [47-50]. Localized
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VEGF expression in scratched samples was assessed using
immunocytochemistry (ICC). We also localized tight and
adherens junctions in short-term (1 day after confluency)
and long-term (4 weeks after confluency) RPE samples
by staining N-cadherin, β-catenin, claudin-1, and ZO-1 to
examine the formation of intercellular junctions. N-cadherin
is the most abundant cadherin in RPE cells that mediates cell–
cell adhesion at adherens junctions and modulates cellular
phenotype [51-55]. Cadherins contribute to the formation of
adherens junctions by associating with β-catenin [56,57].
β-catenin plays a key role in the formation of cadherin–
catenin complexes through linking cadherins to α-catenin
and actin fibers [58]. Claudin-1 is a member of the family of
claudins and a marker of tight junctions [59,60]. ZO-1, another
tight junction protein, belongs to the membrane-associated
guanylate kinases (MAGUK) family [61]. VEGF phosphorylates ZO-1 and increases RPE permeability by disrupting
tight junctions. Increased levels of VEGF also reduce ZO-1
expression in mesothelial, endothelial, and epithelial cells
[62-66]. A recent study showed that in endothelial cells,
reduced ZO-1 expression is associated with alterations in
VEGF expression and cell proliferation [67].
A polydimethylsiloxane (PDMS) stencil patterning
method was used to make micron-sized circular patterns
(as small as 100 μm in diameter) of the ARPE-19 and hRPE
cells. Growing cells on different size patterns produced
varying concentrations of cells with lost junctional adhesions,
allowing quantitative analysis of changes in VEGF expression. Here, using scratching assays and micropatterning techniques, we show a correlation between the loss of intercellular
junctions and increased VEGF expression in RPE cells. Our
findings add new insights into the mechanisms of increased
VEGF expression from RPE cells during retinal degenerative
diseases, such as AMD.
METHODS
Cell culture: ARPE-19 cells were obtained from American
Type Culture Collections (ATCC, catalog no. CRL-2302,
Manassas, VA). Cells between passages 7 and 14 were
grown in standard tissue culture treated plates (Corning Inc.,
Corning, NY) using Dulbecco’s Modified Eagle Medium/
Nutrient Mixture F-12 (DMEM/F-12, Life Technologies,
Carlsbad, CA) supplemented with 10% fetal bovine serum
(FBS, ATCC, catalog no. 30–2020). Growth media were
changed three times a week. ARPE-19 cells were grown
for 4 weeks before use in the experiments. Human primary
RPE cells (hRPE, Lonza, Walkersville, MD) were grown in
RPE cell basal media containing supplements (RtEGM™
BulletKit, Lonza) and used until passage 4. Two percent FBS
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(Lonza) was added to the media for subculturing, and the
media were replaced with serum-free media after 24 h. The
ARPE-19 and hRPE cells were kept in a humidified incubator
at 37 °C in 5% CO2.
Cell authentication: Short tandem repeat (STR) analysis
was used to validate the ARPE-19 cells used in this study.
Passage 15 was analyzed by the University of Arizona’s
Genetics Core’s cell line authentication service. Briefly,
genomic DNA was genotyped for 15 autosomal STR loci and
amelogenin (X/Y) using the Promega PowerPlex 16 HS kit
(Promega Corp., Madison, WI; Catalog no. DC2101). PCR
was performed in an MJ Research Tetrad thermal cycler (MJ
Research, Waltham, MA) using the manufacturer’s recommended cycling conditions. Appropriate positive and negative
controls were also amplified to ensure the accuracy of the
allelic calls and to confirm that the reaction mix is free from
contaminating genetic material. PCR products were separated
with capillary electrophoresis using a 3730 DNA Analyzer
(Applied Biosystems, Foster City, CA). The electropherograms were analyzed using GeneMarker software version
1.85 (SoftGenetics, State College, PA). Alleles were matched
to the STR profile recorded with the German Collection of
Microorganisms and Cell Cultures (Leibniz-Institut Deutsche
Sammlung von Mikroorganismen und Zellkulturen GmbH or
DSMZ). The ARPE-19 cells used in this study matched the
ATCC human RPE (ARPE-19) cell line above the 80% match
threshold, which is considered a match. The STR analysis
results are provided in Appendix 1. The Certification of
Analysis of the hRPE from Lonza is also included as passages
1–4 of the hRPE cells were used to generate the results found
here. Expression of VEGF and the intercellular proteins ZO-1,
N-cadherin, β-catenin, and claudin-1 by the ARPE-19 and
hRPE cells (as demonstrated by the results from enzymelinked immunosorbent assay [ELISA] and ICC) also verified
the identity of the RPE cells.
Scratching assay: ARPE-19 and hRPE cells were cultured in
glass-bottom well plates (Cellvis, Mountain View, CA) until
a confluent monolayer formed (5–7 days). After 1 day (shortterm) or 4 weeks (long-term), the monolayers were manually
scratched using sterile cell scrapers (Corning Inc.) to make
scratches approximately 300 μm wide. The cells were then
washed twice with relevant serum-free culture media. The
scratched monolayers were cultured for 24 h before immunocytochemical staining.
Micropatterning: The method used to fabricate PDMS stencils has been described previously [45,46]. Briefly, arrays
of micropillars with diameters of 100, 200, and 300 μm
were fabricated using SU-8 2100 photoresist (MicroChem,
Corp., Newton, MA, Figure 1A). The space between the
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micropillars was 1 mm for all pattern sizes. The PDMS
prepolymer (Sylgard 184, Dow Corning, Midland, MI) was
prepared by mixing the elastomeric base and curing agent
at a 10:1 v/v ratio, spun on silicon wafers containing the
patterns at 1000 rpm using a CEE® model 200X spin coater,
and cured at 85 °C for at least 2 h (Figure 1B). The cured
PDMS membranes with through holes were peeled off the
silicon wafers using wide-tip tweezers (Figure 1C). A scanning electron microscope (SEM, Quanta FEG 650 model;
FEI, Hillsboro, OR) was used to examine the PDMS stencils.
After the stencils were washed in ethanol, they were placed
on cleaned 12 mm circular glass coverslips. The coverslips
with the PDMS stencils were heat sterilized in an oven for at
least 2 h at 90 °C and transferred to untreated 24-well plates
(Corning Inc.). Fresh growth media (1 ml) were transferred
to the wells containing the coverslips, and the well plate
was degassed in a vacuum chamber for 1 h to remove air
bubbles from the holes of the PDMS stencil. Vacuum degassing is essential for achieving consistent patterning of the
whole coverslip surface. Treating the PDMS stencils with O2
plasma also facilitates the removal of air bubbles. Next, 1 ml
of cells at a density of 106 cells/ml was seeded on the PDMS
stencils to cover the bottom of all through holes in PDMS
with ARPE-19 or hRPE cells (Figure 1D). Cells were grown
on stenciled coverslips until confluency (Figure 1E). One day
after confluency, the PDMS stencils were removed, and the
coverslips were gently washed twice with fresh growth media
(Figure 1F). The patterned coverslips were then transferred to
a new 24-well plate with the wells previously filled with 1 ml
of fresh growth media and incubated until further analyses.
The viability of the micropatterned cells was quantified using
the Trypan blue exclusion assay (Gibco, Logan, UT). Cell
counts were performed based on the nuclear counts. The
nuclei were stained with NucBlue® live cell stain (Thermo
Fisher Scientific, Eugene, OR; catalog no. R37605), and
ImageJ software was used to facilitate counting of the nuclei.
The concentration of cells with a free edge was calculated
for individual cell patches as the ratio of the number of cells
on the periphery of the cell patch (counted based on nuclear
staining and bright-field images) over the total cell count for
that patch of cells.
ELISA: Spent media from cultures of ARPE-19 and hRPE
cells were collected after 24 h of growth and assayed for
VEGF expression using a human VEGF ELISA kit (Life
Technologies, catalog no. KHG0112). This kit measures the
levels of the VEGF165 isoform. Absorbance at 450 nm was
measured using a BioTek Synergy 2 plate reader (BioTek,
Winooski, VT).
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Immunocytochemical staining: Extracellular VEGF expression in the patterned and scratched cultures of the ARPE-19
and hRPE cells was assessed using ICC. VEGF, ZO-1,
N-cadherin, β-catenin, and claudin-1 were stained with
conjugated primary monoclonal antibodies against VEGF
(Novus Biologicals, Littleton, CO), ZO-1 (Thermo Fisher
Scientific), N-cadherin (Novus Biologicals), β-catenin
(Novus Biologicals), and claudin-1 (Thermo Fisher Scientific)
at 1:100 dilution according to the manufacturer’s instructions.
The nuclei were counterstained with NucBlue® live cell stain.
Immunostained samples were imaged using an LSM-710
Carl Zeiss (Jena, Germany) confocal microscope. Cells were
grown on porous cell culture inserts (Costar Scientific Corp.,
Cambridge, MA) before confocal Z-stack scanning of the
long-term cultures was performed. Net signal intensity graphs
for VEGF were calculated over the length of the confocal
images for the scratched samples using Zen 2 software (Carl
Zeiss). A ridge detection plugin [68] for ImageJ software was
used to calculate the total length of the cell–cell junctions and
the length of the junctions covered with junctional proteins
in the confocal images. The percentage of junctions covered
with junctional proteins was calculated as the ratio of the
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length of the lines in the confocal images for relevant junctional proteins over the total length of the junctions.
Statistical analysis: Data are presented as the mean ± standard deviation. Statistical significance was determined using
a Student’s t test with p<0.05 indicating a statistically significant difference. Sample sizes are indicated in each figure and
table.
RESULTS
The effect of losing RPE–RPE adhesion on VEGF expression was first investigated using scratching assays and ICC.
ARPE-19 and hRPE cells were grown for 4 weeks (longterm) after they had reached confluency and then scratched
using a cell scraper. One day after scratching, the cells were
stained with anti-human VEGF antibody, and the nuclei
were counterstained with 4',6-diamidino-2-phenylindole
(DAPI; Figure 2). In addition, ICC was performed on the
scratched cultures of the ARPE-19 and hRPE cells that had
been grown for only 1 day after they reached confluency
(short-term cultures). Confocal imaging of the scratched
samples showed that disrupting RPE–RPE contact amplified

Figure 1. Schematic of PDMS stencil fabrication and micropatterning. A: Microfabricated photoresist pillars on a silicon wafer. B:
Polydimethylsiloxane (PDMS) prepolymer spun on a silicon wafer with photoresist patterns. C: Peeling the cured PDMS stencil off the
silicon wafer. D: Illustration of cell seeding on the stenciled coverslips. E: Representative schematic of the formation of the RPE monolayer.
F: Characteristic circular pattern of the RPE cells after the PDMS stencil is peeled off the coverslip.
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VEGF expression in the cells on the edges of the scratched
areas in the short- and long-term RPE cultures (Figure 2).
In the confocal images, a marked decrease in the net signal
intensity for VEGF was observed from the scratch edge
toward the middle of the monolayer in all scratched samples
(Figures 2D,H,L,P). VEGF intensity was also averaged over
two intensity bins at 0–100 μm and 100–200 μm from the
scratch edge. For the ARPE-19 and hRPE scratch samples,
the average signal intensity of the VEGF channel was higher
in the 0–100 μm distance. To visualize the formation of the
intercellular junctions, we used ICC to stain for the tight
junction components (ZO-1 and claudin-1) and the adherens
junctions (N-cadherin and β-catenin) in the short- and longterm cultures of the ARPE-19 (Figure 3) and hRPE (Figure
4) cells. According to the ICC results, ZO-1, N-cadherin,
β-catenin, and claudin-1 were localized to the intercellular
space in the long-term cultures (n = 3). ZO-1 was present in
88 ± 5.0% of the cell–cell junctions in the ARPE-19 cells and
98 ± 2.0% of those in the hRPE cells (Table 1). High levels
of junctional localization were also seen for N-cadherin (93
± 6.0% in the ARPE-19 cultures and 69 ± 17% in the hRPE
cultures), β-catenin (82 ± 8.0% in the ARPE-19 cultures and
49 ± 13 in the hRPE cultures), and claudin-1 (only 10 ± 5.0%
in the ARPE-19 cultures and 53 ± 6.0% in the hRPE cultures,
Table 1). In the short-term cultures (n = 3), however, only
ZO-1 was junctionally localized, with 64 ± 14% and 84 ±
7.0% of the junctions covered with ZO-1 in the ARPE-19
and hRPE cultures, respectively (Table 1). The percentage of
junctional coverage with claudin-1 and β-catenin in both cell
types and N-cadherin in the hRPE cultures was less than 10%
in the short-term cultures. In the short-term cultures of the
ARPE-19 cells, only slightly more than 25% of cell junctions
were covered with N-cadherin (Table 1). We also performed
a confocal z-stack scan on the long-term ARPE-19 and hRPE
cultures grown on the porous cell culture inserts to confirm
the polarization of the RPE cells. The results showed that in
the long-term ARPE-19 cultures, although ZO-1 successfully
localized to the apical regions, VEGF failed to polarize properly because its expression was not localized to either side
of the culture (Figure 3M). In the long-term hRPE cultures,
ZO-1 was localized to apical and intercellular areas, and the
expression of VEGF was mainly basolateral, confirming the
polarization of cells after 4 weeks (Figure 4M).
Results of the scratching experiments followed by ZO-1
and VEGF staining showed that in the ARPE-19 and hRPE
cultures, VEGF expression was higher on the edges of the
cell patches, where the cell–cell contact was missing, and
lower in the confluent areas of the monolayer with higher
ZO-1 junctional localization. VEGF expression was inversely
proportional to the localization of ZO-1 to the intercellular
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junctions. In other words, with less junctional localization of
ZO-1, VEGF expression was higher and vice versa (Figure
5A–C).
Based on the scratching results, we hypothesized losing
intercellular junctions, and therefore, reduced cell–cell
interactions, may contribute to increased VEGF expression.
Inducing VEGF expression from cells with a free edge in the
short-term scratched cultures suggests that intercellular junctions that occur early after cell–cell contact, such as ZO-1,
may be involved in VEGF regulation. To verify these results,
we used a micropatterning method to quantitatively study and
control the loss of cell–cell contact on VEGF expression in
short-term cultures of ARPE-19 and hRPE cells.
For micropatterning, a PDMS stencil micropatterning
method was used to make micropatterns of the RPE cells.
The SEM images showed that the diameter of the through
holes in the PDMS membranes was 102.7 ± 4.60, 213.4 ±
3.800, and 307.3 ± 10.50 μm for the 100, 200, and 300 µm
patterns, respectively (n = 9; Figure 6A–C; Table 2). These
membranes made consistent circular patterns of ARPE-19
and hRPE cells on the glass substrates. Figure 6D–F shows
ARPE-19 cells attaching to the exposed glass in the presence
of PDMS stencils. Figure 6G–I shows single patches of hRPE
cells patterned on glass coverslips after the PDMS stencil
was removed. Figure 7A shows that varying concentrations
of cells on the periphery of the patterns could successfully
be produced using this micropatterning method. The average
cell patch size was 101.5 ± 4.000, 213 ± 11.0, and 311.5 ±
10.00 μm in diameter, and the average cell count per patch
was approximately 6.0 ± 2.0, 28 ± 6.0, and 96 ± 16, respectively (n = 21; Table 2). Patterning on the smallest pattern size
(100 μm) produced the highest concentration of peripheral
cells with approximately 93% of all cells losing junctional
cell–cell adhesion at least on one side. This percentage
decreased to 54 and 33 for the 200 and 300 μm pattern sizes,
respectively (n = 21; Figure 7A; Table 2). The size of the cell
patches increased for both cell types 48 h after the stencil
was removed, with this increase greater for ARPE-19 patches
(Figure 7B). The viability of micropatterned ARPE-19 and
hRPE cells was greater than 93% for all pattern sizes.
ICC was used to localize the expression of ZO-1 and
VEGF in the micropatterned samples. The results showed
that the expression of VEGF was higher on the periphery
of the ARPE-19 and hRPE micropatterns. Similar to the
scratched samples, this increase in VEGF expression was
associated with the translocation of ZO-1 from the junctional
zones (Figure 5D–I). VEGF expression in the spent media
of the patterned ARPE-19 and hRPE cells was analyzed
using a VEGF ELISA kit (n = 9). To quantitatively compare
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Figure 2. ICC results for scratched cultures of ARPE-19 and hRPE cells. Results show confocal images for short-term (1 day after confluency)
and long-term (4 weeks after confluency) cultures of ARPE-19 (A-C, E-G) and hRPE (I-K, M-O) cells. VEGF expression was elevated along
the edges of scratched areas in all sample types. Graphs D, H, L, and P show net signal intensity for VEGF along the length of the relevant
confocal image (line graphs) and the average VEGF signal intensity at 0-100 μm and 100-200 μm from the scratched edge (bar graphs). The
net signal intensity was higher proximal to the scratch zone and lower in confluent areas for all samples. The average signal intensity was
higher in the first 100 μm from the scratch edge for all samples. Blue = 4',6-diamidino-2-phenylindole (DAPI); red = VEGF. Yellow lines
indicate the scratch edge. Scale bars = 100 μm.
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Figure 3. ICC results for confluent
ARPE-19 cultures. Cells were
immunostained for Claudin-1 (A,
B), N-cadherin (C, D), β-catenin
(E, F) and ZO-1 (G, H). I-L:
Percentage of intercellular junctions covered by the corresponding
protein in cultures of ARPE-19
cells grown for 1 day or 4 weeks
after reaching confluency. All junctional proteins, except for ZO-1, had
limited localization after 1 day at
confluence. In all cases, junctional
localization increased significantly
after 4 weeks. Data represent the
mean ± standard deviation for three
replicates from three representative
confocal images per each time point
for each junctional protein (n = 3).
* p<0.05, ** p<0.01. M: Z-stack
scan for a long-term (4 weeks
after conf luency) of ARPE-19
cells grown on porous cell culture
inserts. ZO-1 was localized to
the apical junctional areas, while
VEGF failed to polarize. Scale bar
= 25 μm.
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Figure 4. ICC results for confluent
hRPE cultures. Cells were immunostained for Claudin-1 (A, B),
N-cadherin (C, D), β-catenin (E, F)
and ZO-1 (G, H). I-L: Percentage
of intercellular junctions covered
by the corresponding protein in
cultures of hRPE cells grown for
1 day or 4 weeks after reaching
confluency. All junctional proteins,
except for ZO-1, had limited localization after 1 day post confluence.
In all cases, junctional localization
increased markedly after 4 weeks.
Data represent the mean ± standard deviation for three replicates
from three representative confocal
images per each time point for each
junctional protein (n = 3). * p<0.05,
** p<0.01. M. Z-Stack scan for a
long-term (4 weeks after confluency) culture of hRPE cells grown
on porous cell culture inserts,
confirming apical localization of
ZO-1 and basolateral localization
of VEGF. Scale bar = 25 μm.
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Table 1. Percentage of cell- cell junctions covered with junctional proteins,
Claudin-1, N- cadherin, catenin and ZO-1, in short-term (1 day after confluence) and
long -term (4 weeks after confluence) cultures of ARPE-19 and h RPE cells.
Cell type
ARPE-19
hRPE

Time after
confluence

Cell-cell junctions covered with junctional protein (%)
Claudin-1

N-cadherin

β-catenin

ZO-1

1 Day

0

4 Weeks

10±5

26±5

5±3

64±14

93±6

82±8

88±5

1 Day

0

8±6

6±5

84±7

4 Weeks

53±6

69±17

49±13

98±2

Data represent the mean ± standard deviation for 3 replicates (3 representative confocal images for each
junctional protein and each time point; n = 3).

VEGF expression in cells grown on different pattern sizes,
specific VEGF expression was calculated by dividing the
total VEGF measured in the spent media after 24 h by the
total number of cells (VEGF/ml.cell). With smaller pattern
sizes, increasing levels of VEGF expression were observed
from the ARPE-19 and hRPE cells (Figure 7C,D). To further
investigate the effect of the patch size, the cells were grown

for another 24 h in fresh media before the spent media were
analyzed for VEGF expression. Specific VEGF expression
slightly decreased at day 2. This change in VEGF expression
at day 2 was greater in the ARPE-19 patterns (Figure 7C,D).

Figure 5. Confocal ICC images
of scratched and micropatterned
RPE cultures. ZO-1 and VEGF
were immunostained in a longterm hRPE culture (4 weeks after
confluency) 24 h after scratching
(A-C) and micropatterned hRPE
(D-F) and ARPE-19 cells (G-I) 24
hours after removing PDMS stencils. VEGF expression increased in
cells proximal to the scratched area
(A) and along the periphery of the
micropatterns (D, G). This increase
in VEGF expression correlated
with dislocalization of ZO-1 from
intercellular zones to the cytoplasm
in both scratched and micropatterned samples (B, E, H). Red =
VEGF; green = ZO-1. Yellow lines
indicate the scratch edge (A-C) and
micropattern edges (D-I). Scale bar
= 50 μm.
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DISCUSSION
Although there is a large body of evidence linking increased
VEGF expression in the RPE to pathologic neovascularization of the retina [3-10], the exact mechanisms leading to the
imbalance of VEGF in wet AMD are not fully understood.
The failure of RPE–RPE adhesion is known as a consequence
of neovascularization but is not usually considered a mechanism that contributes to the pathogenesis of CNV. The present
study demonstrates that losing RPE–RPE attachment can
induce VEGF overexpression and that early cell–cell contact
can regulate VEGF expression.
Scratching and micropatterning methods were developed to study the role of junctional RPE adhesion on VEGF
expression. In particular, immunostaining the scratched
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samples for VEGF showed a higher level of VEGF in cells
with lost junctional adhesion mainly on the edges of the RPE
cell monolayers (Figure 2), suggesting a regulatory role for
RPE cell–cell adhesion in VEGF expression. Junctional
localization of claudin-1, N-cadherin, β-catenin, and ZO-1
in long-term hRPE cultures and the polarization of VEGF
and ZO-1 expression demonstrated the proper formation of
the intercellular junctions and the maturity of the hRPE cells.
Despite the lack of proper polarization of ARPE-19 cells in
the long-term cultures, the effect of losing cell–cell adhesion on VEGF expression in the ARPE-19 cells was similar
to that in the hRPE cells. Aberrant localization of VEGF in
ARPE-19 cells has previously been observed [50,69]. Here,
we found that overexpression of VEGF occurs in short-term
cultures, implying that early contact between neighboring

Figure 6. Micropatterning of ARPE-19 and hRPE cells. A–C: Scanning electron microscope (SEM) images of through holes of different
sizes (A: 100, B: 200, and C: 300 μm in diameter) in the polydimethylsiloxane (PDMS) stencils. The lateral spacing between the holes was
1 mm for all pattern sizes. D–F: ARPE-19 cells attached to glass coverslips through PDMS stencil holes after 24 h. G–I: hRPE cells on
glass coverslips, after the PDMS stencils were removed. Scale bars, A–C = 500 μm; D–I = 200 μm.
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Table 2. Micropatterning results.
Nominal Pattern Size (μm)
Diameter of Through Holes in PDMS Stencils (μm)
Day 0
ARPE-19
Cell Patch Diameter (μm)
hRPE

100

200

300

102.7±4.6

213.4±3.8

307.3±10.5

101.5±4

213±11

311.5±10

Day 1

120.3±14

225.3±13

349.2±26

Day 2

176.2±23

355.3±27

488.8±43

Day 0

101±6

210±10

308±12

Day 1

108.8±7

217.7±12

326.2±16

Day 2

121.8±14

240±29

369.8±44

Cell Count (Cells/Patch)

ARPE-19

Day 0

6±2

28±6

96±16

Concentration of Cells with a
Free Edge (%)

ARPE-19

Day 0

93±7

54±7

33±4

Day 0 measurements taken immediately after removing the PDMS stencils. Day 1 and 2 are 1 and 2 days
after removing the PDMS stencils, respectively. Data represent the mean ± standard deviation for three
replicates. For the diameter of through holes in PDMS, three measurements per pattern size per replicate
(n = 9) are reported. For the cell patch measurements, seven measurements per replicate (n = 21) for each
pattern size and each time point are listed.

Figure 7. Micropatterning results.
A: Formation of varying concentrations of ARPE-19 cell with a free
edge by micropatterning. Black =
average number of cells per cell
patch of corresponding size; red
= concentration of cells losing
cell–cell contact at least on one
side. Increase in the concentration
of cells losing cell–cell contact
correlates negatively with cell count
and patch size. Data represent the
mean ± standard deviation for three
replicates (seven measurements per
replicate for each pattern size and
each time point; n = 21). Similar
results were seen for the human
RPE (hRPE) cells (data not shown).
B: Increase in the cell patch diameter at day 2. A greater increase in
patch diameter was observed for the
ARPE-19 cells compared with the hRPE cells. Data represent the mean ± standard deviation for three replicates (seven measurements per
replicate for each pattern size and each time point; n = 21). C, D: VEGF expression analysis with enzyme-linked immunosorbent assay
(ELISA) for the micropatterned ARPE-19 (C) and hRPE (D) cells. VEGF expression is presented as the total VEGF divided by the cell count.
The smaller the pattern size, the higher the VEGF expression per cell. VEGF expression decreased during day 2 presumably because of the
increased pattern sizes due to cell growth (B). Data represent the mean ± standard deviation for three replicates (three measurements per
replicate for each pattern size and each time point; n = 9); * p<0.05, ** p<0.01, *** p<0.001. P values are relative to the control (confluent)
samples.
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cells is a key step in VEGF regulation. Therefore, it is likely
that early-forming junctional complexes have a role in regulating VEGF expression.
Figure 2 shows that VEGF is induced in the RPE cells
at the edges of the scratched areas. According to the ICC
results (Figure 3 and Figure 4), ZO-1 is one of the first junctional proteins to localize to intercellular zones. Figure 5
shows that the delocalization of ZO-1 correlates strongly to
increased VEGF expression in the scratched zones and along
the periphery of the micropatterns. ZO-1 is an important
component of intercellular signal transduction in epithelial
and endothelial cells [70,71]. Previous studies have implicated
VEGF in the phosphorylation and delocalization of ZO-1
[66,72]. A recent study showed that changes in ZO-1 expression can affect VEGF expression in endothelial cells [67].
Moreover, aberrant angiogenesis has been reported in the
yolk sac of ZO-1-deficient mice [73]. In RPE cells, inhibiting
ZO-1 expression induces proliferation. More effort is needed
to clarify whether ZO-1 or other junctional proteins that
contribute to early stages of junction formation can regulate
VEGF expression in RPE cells. Nevertheless, our results
show a clear relationship between the loss of junctional RPE
cell adhesion and VEGF expression.
To quantitatively evaluate the hypothesis that the
observed increase in VEGF expression is due, at least in part,
to reduced cell–cell contact, we produced varying concentrations of cells with reduced cell–cell contact by growing RPE
cells on different pattern sizes (Table 2; Figure 7A) using
micropatterning. One advantage of the physical detachment of cells by micropatterning compared with chemical
methods, such as calcium-mediated dissociation, is that
it eliminates any possible side effect on VEGF expression
from the chemicals typically used for dissociating cellular
junctions [74]. By using PDMS stencils, we also eliminated
the need for cell adhesion proteins, which may affect VEGF
expression [14]. The quantitative ELISA results from the
micropatterning experiments confirmed our hypothesis that
losing cell–cell adhesion increases VEGF expression (Figure
7C,D). These findings confirm previous observations from
calcium-mediated RPE dissociation studies [32,33]. In the
patterning experiments, the ARPE-19 cells behaved similarly
to the hRPE cells in terms of VEGF expression. The VEGF
expression from ARPE-19 cells was only slightly lower than
that of the hRPE cells. The decreased VEGF expression at
day 2 of patterning, observed for both cell types, is presumably due to cell growth leading to an increase in patch size
and consequently the decreased concentration of the cells on
the edges of the patterns. This change in VEGF expression
at day 2 decreased to a greater extent in the ARPE-19 cells
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than in the hRPE cells, potentially due to the shorter doubling
time of the ARPE-19 cells compared with that of the hRPE
cells, leading to faster growth of the size of the cell patches
(Figure 7B–D).
During the latest stages of dry AMD, the loss of physical
contact between RPE cells occurs due to RPE cell death in
GA [29-31]. In a study on patients with AMD with GA, CNV
started at the peripheral borders of the atrophic sites in nearly
70% of the eyes that developed CNV, implying that cell–cell
contact may have a role in the progression of dry AMD to
wet AMD [75]. RPE cells may also physically detach from
each other because of breaks (tears) in the RPE monolayer.
RPE tears occur spontaneously secondary to neovascular
AMD or after intravitreal injection of antiangiogenic drugs
[20-28]. The present findings suggest that physical perturbations in the RPE, which may result from RPE degeneration,
RPE tears, drusen formation, or apoptosis associated with
aging, can induce the initiation and/or progression of CNV
due to the overexpression of VEGF. Particularly, our results
are consistent with a previous finding that the expression of
VEGF isoforms was markedly increased in the RPE cells
along the edges of a surgically removed subretinal vascular
membrane of a patient with AMD [33]. The present results
may also explain observations that CNV is associated with
the surviving RPE cells in atrophic areas of retinas with
AMD [76]. It is possible that this association of CNV with
surviving RPE cells may be a consequence of tight junction
loss and increased VEGF expression in and from RPE cells at
atrophic sites. Given that CNV occurs during the latest stages
of AMD, it may be possible to prevent CNV by implementing
anti-VEGF therapies earlier, as soon as defects in RPE–RPE
integrity are detected. Moreover, the present findings suggest
that anti-VEGF therapies may be required even after the
development of RPE tears to prevent excessive VEGF expression due to the loss of cell–cell contact in the RPE.
The ELISA kit used here can quantify the levels of
VEGF165. This isoform is the most potent and most abundant
VEGF isoform in the RPE [77,78]. Nevertheless, further
research is needed to study the effect of losing cell–cell
contact on the expression of other isoforms of VEGF, such
as VEGF121, and to identify the association between RPE
cell–cell signaling and VEGF overexpression in wet AMD.
Work in this direction is ongoing in our laboratory.
Conclusions: Increasing the loss of cell–cell contact induced
VEGF protein expression in ARPE-19 and hRPE cells. In
addition, we demonstrated that there is a correlation between
the loss of intercellular junctions and increased VEGF
expression.
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To access the data, click or select the words “Appendix 1.”
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